Clinical benefits and cost saving of achieving composite treatment targets for type 2 diabetes – A modeling study
In this modeling study, a sustained achievement of CTT led to improved clinical benefits and significant direct medical cost savings. The longer the achievement period and the more stringent CTT, the greater the clinical benefits and cost savings.
Authors
- R. Wang
- Jinnan Li (ORCID: https://orcid.org/0009-0001-2600-956X)
- Beatrice Osumili (ORCID: https://orcid.org/0000-0002-5862-9325)
- Y Liu
- Si Si
- Yuchen Ding
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1080/13696998.2025.2604454
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00